Ingham, M., Allred, J. B., Chen, L., Das, B., Kochupurakkal, B., Gano, K., George, S., Attia, S., Burgess, M. A., Seetharam, M., Boikos, S. A., Bui, N., Chen, J. L., Close, J. L., Cote, G. M., Thaker, P. H., Ivy, S. P., Bose, S., D’Andrea, A., … Schwartz, G. K. (2023). Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250). Journal of Clinical Oncology, 41(25), 4154–4163. https://doi.org/10.1200/jco.23.00402
Subjects:
Leiomyosarcoma
(MeSH)
Uterine Neoplasms
(MeSH)
Publication Type:
Article
Unique ID:
10.1200/jco.23.00402
PMID:
DOI:
Journal:
Publication Date:
Data Source:
PubMed
Source Link: